Applications
ELISA
SPR Analysis
Antibody Discovery
Antibody Screening
Immunization
PD/PK
Research and development for antibody drugs has increasingly fierce competition. The discovery of antibodies specific to difficult targets can help you maintain competitiveness in the market.
Nanoparticles (20-200nm) derived from outer capsid protein of virus
Formed by the automatic assembly of one or more viral capsid proteins
Surface display provides multiple copies of antigen per VLP to enhance immunogenicity
Do not contain viral infectious genomes, making them safe to use in manufacturing operations
Efficiently activate the body’s humoral and cellular immune responses
Natural configuration of transmembrane proteins for discovery of differentiated antibodies
ELISA
SPR Analysis
Antibody Discovery
Antibody Screening
Immunization
PD/PK
Transmembrane proteins
High activity
High immunogenicity
Soluble expression of different proteins
Clear structure
Not pathogenic
Let us know if you're looking for a VLP or modification not listed on our site. KACTUS can provide customization of VLP-displayed antigens.